TrialDiabetes, obesity & metabolism2022

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.

John P H Wilding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.